Diagnostic technologies for neuroblastoma
Leena Khelifa, Yubing Hu, Jennifer Tall, Rasha Khelifa, Amina Ali, Evon Poon, Mohamed Zaki Khelifa, Guowei Yang, Catarina Jones, Rosalia Moreddu, Nan Jiang, Savaş Taşoğlu, Louis Chesler, Ali K. Yetisen
Abstract
amplification and microRNAs (miRNAs). Using POC devices to detect high-risk biomarkers in biofluids such as blood and urine, offers a non-invasive approach to diagnosis of neuroblastoma, enabling early screening at a population level as well as real-time health monitoring at home. This is critical to mitigating long-term morbidity associated with late diagnosis and unnecessary treatment, in turn improving outcomes for neuroblastoma patients.
Topics & Concepts
NeuroblastomaMeaning (existential)Computer scienceDiagnostic testMedical physicsEngineeringMedicineSystems engineeringRisk analysis (engineering)BiologyPsychologyPediatricsCell cultureGeneticsPsychotherapistNeuroblastoma Research and TreatmentsIon channel regulation and functionCancer, Hypoxia, and Metabolism